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MitochondriaHelicobacter pylori causes various gastric diseases, such as gastritis, peptic ulcerations, gastric cancer and
mucosa-associated lymphoid tissue lymphoma. Hpn is a histidine-rich protein abundant in this bacterium and
forms oligomers in physiologically relevant conditions. In this present study, Hpn oligomers were found to
develop amyloid-like ﬁbrils as conﬁrmed by negative stain transition electron microscopy, thioﬂavin T and
Congo red binding assays. The amyloid-like ﬁbrils of Hpn inhibit the proliferation of gastric epithelial AGS cells
through cell cycle arrest in the G2/M phase, which may be closely related to the disruption of mitochondrial
bioenergetics as reﬂected by the signiﬁcant depletion of intracellular ATP levels and the mitochondrial
membrane potential. The collective data presented here shed some light on the pathologic mechanisms of
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Abnormal protein aggregation and deposition of misfolded pro-
teins have been recognized as a common pathological feature of the
neurodegenerative diseases, such as Alzheimer's disease (AD), prion
diseases, Parkinson's disease and the poly(glutamine) (polyQ) disease
[1]. Alzheimer's disease is a neurodegenerative disorder of the elderly
that is characterized by progressive cognitive deterioration. It has been
suggested that the most toxic form to cause memory loss may be the
small diffusible oligomers, or the protoﬁbrils, rather than the mature
amyloid ﬁbers [2]. One notable characteristic of AD is the highly
enriched metal concentrations in the brain: four times higher Cu2+
levels in the AD neuropil than in the neuropil of a healthy brain [3],
whichhas been supportedby several hot spotswithhighly concentrated
Cu2+ and Zn2+ within Aβ-associated amyloid plaques [4].
Aβ undergoes a conformational transition from a soluble random
coil to an insoluble ﬁbrillar β-sheet rich form. The trigger to promote
oligomerization and ﬁbril formation is still a subject of debate. Zn2+
and Cu2+ can be involved in promoting [5,6] or inhibiting [7] theamyloid ﬁbril formation. Smith et al. [8] suggested that the
controversial results are possibly attributed to the Cu2+/peptide
molar ratio: at sub-equimolar ratios, Aβ(1–42) forms amyloid ﬁbrils;
at supra-equimolar ratios, Aβ(1–42) forms small spherical oligomers
(approx. 10–20 nm in size) and large amorphous aggregates. Several
animalmodel experiments seem to favor the role of Cu2+ in promoting
ﬁbril formation: (1) copper chelators can reverse the aggregation and
cause solubilization of amyloid deposits from post-mortem AD brain
tissue [9]; and (2) trace amounts of copper induce amyloid plaques
and learning deﬁcits in a rabbit model of AD [10].
The polyQ diseases are caused by abnormal expansions of the
polyQ stretch to more than 40 glutamine residues and the subsequent
aggregation of the protein [11]. One molecular dynamic study of the
polyQ protein ribonuclease A indicated that the ﬁbrillar structure is
stabilized by the highly dense packing of Gln side chains, through
intra-sheet hydrogen bonding interactions of the amide stacks and
inter-sheet van der Waals interactions of their alkylic parts in the
steric zipper [12]. Previously we hypothesized that histidine-rich
proteins, such as Hpn fromHelicobacter pylori [13], histidine-rich Ca2+
binding protein (HRC) from Sarcoplasmic reticulum [14] and imidazole
glycerol-phosphate dehydratase from Filobasidiella neoformans [15],
tend to form high order of oligomers, probably induced by aromatic
stacking between intra- or inter-molecule imidazole side chains of
histidine residues [13]. The experimental evidence of the direct
involvement of histidine protonation in the formation of amyloid has
been identiﬁed in such proteins as β-amyloid, prion protein (PrP),
islet amyloid polypeptide (IAPP), β-2-microglobulin [16] and HDL-
associated serum amyloid A [17].
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ulcerations [18]. The development of gastric carcinoma and MALT
(mucosa-associated lymphoid tissue) lymphoma is also strongly
associated with chronic H. pylori infections [19,20]. H. pylori produces
a small cytoplasmic protein, Hpn, which accounts for approx. 2% of
total proteins synthesized by H. pylori [21] and has 28 histidine
residues among its 60 amino acids. The majority of the histidine
residues lie in the central part of the protein with two stretches of six
and seven consecutive histidine residues. Another feature of the Hpn
is the presence of 20 pairs of one speciﬁc amino acid, including 12
pairs of His, two pairs of Cys, three pairs of Glu, two pairs of Gly and
one pair of Ser, which seems to suggest sequence self-repeating from
an ancient monomeric origin. It is of note that among its 42 amino
acids, Aβ(1–42) is also rich in pairs of one speciﬁc amino acid, i.e., one
pair each of His, Phe, Ile, Gly and Val. Hpn has been proposed to play a
role in nickel storage, homeostasis and detoxiﬁcation [22,23]. In
physiologically relevant conditions, Hpn is present in an equilibration
of multimeric forms: with the 20-mers (ca. 136 kDa) being the
predominant species [13], and this protein represents a novel class of
metal binding proteins with the relative binding afﬁnities: Cu2+N
Ni2+NBi3+≈Zn2+ [24]. EPR data indicated that Cu2+ ions have a 4N
(four histidines) or 3N1O/S (three histidines plus one oxygen/sulfur
donor ligand) ligand environment during the binding to Hpn. Similarly,
Aβ(1–42) has a picomolar afﬁnity to Cu2+with the coordinating ligands
to be the three histidine imidazole nitrogens and two carboxylate
oxygens [25].
Considering the various aspects in common between Hpn and
amyloidogenetic peptides, we checked whether Hpn oligomers form
amyloid-like ﬁbrils in this present study. The cytotoxicity of Hpn
oligomers to gastric epithelial cells was also investigated to deduce
the possible biological meanings. The formation of amyloid ﬁbrils by
Hpn protein was conﬁrmed by transition electron microscopy,
Thioﬂavin T and Congo red binding assays. The amyloid ﬁbrils of
Hpn inhibit the proliferation of gastric epithelial AGS cells through cell
cycle arrest and the disruption of mitochondrial bioenergetics.
Possible involvement of Hpn amyloidogenesis in the pathologic
mechanisms for H. pylori infections was discussed.
2. Materials and methods
2.1. Materials
Chemicals were of the highest reagent grade commercially
available and used without further puriﬁcation. Stock solutions
were prepared by dissolving anhydrous salts in Milli-Q (Millipore)
puriﬁedwater and adjusted to the desired pH values with 1.0 MNaOH
or HCl whenever needed. Congo red and Thioﬂavin T (ThT) were pur-
chased from Sigma.
2.2. Hpn protein preparations
Recombinant Hpn protein was overexpressed and puriﬁed as
described previously [13]. Brieﬂy, a saturated overnight culture of
E. coli BL21(DE3) transformed previously with the Hpn-expression
plasmid pET-hpn was diluted into the LB media supplemented with
100 μg/ml ampicillin, 0.5 mM NiSO4 and 0.5% glucose. Protein
expression was induced with the addition of IPTG (0.5 mM) when an
OD600 of 0.7 was reached, and the cultures were then incubated for
another 4 h. Cells were harvested and resuspended in 10 ml of ice-
cold Buffer A (20 mM sodium phosphate buffer, 500 mM NaCl, 100 mM
imidazole, 1 mM PMSF, pH 7.4) per liter of cell culture. Bacteria were
ruptured by sonication in the presence of 1% v/v Triton X-100. The
lysates were centrifuged at 14,000 g for 30 min. The supernatant was
loaded onto a home-made Ni-NTA resin column (1 ml, Roche). The
columnwas washed with 10 ml of Buffer A, and then Hpn protein waselutedwith 4 ml of Buffer B (20 mM sodium phosphate buffer, 500 mM
NaCl, 500 mM imidazole, pH 7.4).
2.3. Hpn binding to amyloid-diagnostic dyes
Hpn aggregates were tested for Congo red binding by the
spectroscopic band-shift assay as described [26]. Proteinswere diluted
to a ﬁnal concentration of 10 μM in a buffer containing 20 mMTris (pH
7.2) and 10 μM Congo red, and incubated for 30 min at ambient
temperature. For the ThT assay, Hpn proteins were diluted to 10 μM
with 20 mMTris buffer (pH 7.2), and a ﬁnal concentration of 5 μMThT
was added. The ﬁbrillation kinetics was followed with a Shimadzu
RF5301 spectrophotometer at an excitationwavelength of 450 nmand
an emission wavelength of 482 nm.
2.4. Transmission electron microscopy
Samples (10 μl) were absorbed on 400-mesh copper grids for
2 min,washed twicewith deionizedwater andnegatively stainedwith
1% (wt/vol) uranyl acetate for 90 s. Fibril aggregateswere visualized at
100 kV on a Philips Tec-Nai 10 microscope.
2.5. Proliferation assay
Gastric epithelial AGS cells were maintained at 37 °C in an
atmosphere of 5% CO2 in RPMI 1640 medium containing 5% FBS,
100 U/ml penicillin, and 100 μg/ml streptomycin. Around 5000 cells/
well were grown in 96-well plates and incubated overnight. The cells
were then treated with various concentrations of Hpn ﬁbrils of 5-day
age for 8 h. MTT (Sigma) labeling reagent was added into each well,
and the cells were incubated for another 4 h. The supernatant was
removed, and 100 μl of hydrochloric acid (40 mM) in isopropanol was
added to each well. The optical densities were measured at 590 nm
with a reference ﬁlter at 620 nm.
2.6. Cell cycle analysis
Cells either treated with 4.2 μM Hpn ﬁbrils or untreated (buffer
only without Hpn ﬁbrils) for 8 h were harvested, washed twice with
cold PBS, ﬁxed by vortexing in 70% ice-cold ethanol, treated with
RNase, stained with propidium iodide (PI) and then analyzed by
FACStar Plus ﬂow cytometry, as previously reported [27]. TheWinMDI
2.9 software was used to calculate the percentage of the populations
in sub-G0/G1, G0/G1, S and G2/M phases.
2.7. Mitochondrial transmembrane potential (ΔΨm)
Mitochondrialmembrane potential wasmeasured by the lipophilic
cationic probe, 5,5′,6,6′-tetrachloro-1,1′3,3′-tetraethylbenzimidazo-
lylcarbocyanine iodide (JC-1; Molecular Probes) as described previ-
ously [27,28]. Cells were incubatedwith 5 μΜ JC-1 for 30 min and then
washed with PBS. Mitochondrial membrane potential depletion was
observed under a ﬂuorescence microscope. A green ﬁlter was used for
green-ﬂuorescent monomer at depolarizedmembrane potential and a
red ﬁlter for orange-ﬂuorescent J-aggregate at hyperpolarized mem-
brane potentials.
2.8. ATP assay
Cells were seeded into 96-well plate without or with the treatment
of 4.2 μMHpn ﬁbrils. At time intervals, cellswere harvested andwashed
twice in cold TE buffer (20 mM Tris–HCl, pH 7.8, 2 mM EDTA), and
resuspended in hot TE buffer for 20 min. ATP levels were determined
for the supernatant after centrifugation of the cell suspension, with a
luciferase–luciferin enzymatic assay kit from Molecular Probes. The
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supernatant.
3. Results
3.1. Hpn forms ﬁbers in vitro
ThT ﬂuorescence has been described as a speciﬁc marker for the
crossed β-pleated sheet conformation of amyloid structure [29], as
enhancement in the ﬂuorescence of ThT occurs once binding to
amyloid ﬁbrils. The formation of amyloid-like ﬁbrils of recombinant
Hpn was veriﬁed and monitored using the ThT binding assay. It was
observed that the amyloidogenic process of Hpn follows a sigmoidal
time course with distinguishable lag (formation of a critical nucleus),
exponential (ﬁbril elongation) and plateau phases (exhaustion of
soluble monomers and intermediates) (Fig. 1a), which was basically
attributed to a nucleated polymerization process. The lag phase is a
rough measure of the kinetics in spontaneous ﬁbril growth and the
time frame of the formation of small amounts of ﬁbrils and preﬁbrillar
aggregates. In this present study, Hpn amyloidogenesis was found to
have a pronounced lag phase of 3 days, indicating the difﬁculty in the
primary formation of the ﬁbril nuclei.
Congo redhas been suggested tobind theβ-pleated structure among
the amyloid ﬁbrils through a combination of hydrophobic and elec-
trostatic interactions. Congo redaloneexhibits anabsorbancemaximum
of 490 nmwhich blue-shifts upon binding to the amyloid ﬁbrils [26,30].
Fig. 1b showed the differential absorption spectra of Congo red
incubated in the presence of Hpn aggregates, which indicated that
Hpn aggregates promoted a strong shift of the absorbance maximum
from 490 nm to 540 nm (as a shoulder peak), as described for some
other amyloid ﬁbrils [26,31].
Transmission electron microscopy was used to analyze the struc-
tural changes during Hpn amyloidogenesis. TEM analysis conﬁrmedFig. 1. Formation of amyloid-like ﬁbril structure for Hpn asmonitored by TEM and binding as
ﬁbril structure for Hpn monitored by ThT binding. (b) Absorbance difference spectrum of Co
as identiﬁed under TEM. (c) Protoﬁbrils were abundant at early exponential growth phas
(e) Fibrils aggregate together at later time points. The scale bar is equal to 450 nm.that Hpn aggregates have an amyloid-like ﬁbrillar structure (Fig. 1c–e).
Four days after puriﬁcation, regular and unbranched ﬁbers were readily
observed, along with spherical aggregates (Fig. 1c). These small
spherical aggregates may represent early amyloid intermediates [32]
or small diffusible globular oligomers as identiﬁed in the gel ﬁltration
experiments [13]. Densely branched ﬁbril aggregates were identiﬁed
13 days after puriﬁcation (Fig. 1d). At later stage (over 15 days), mature
amyloid ﬁbrils aggregate together (Fig. 1e). The ﬁbril branching
demonstrated the central role of ﬁbril-dependent nucleation in amyloid
ﬁbril growth [33], which conﬁrmed the sigmoidal time course of Hpn
amyloidogenesis with the ThT assay.
3.2. Hpn exerts its cytotoxicity against AGS cells
Due to the established cytotoxic effects of amyloidogenic peptides
on mammalian cells and our previous ﬁndings of the extracellular
presence of Hpn, the possible effect of this protein on the proliferation
of gastric cancer cell line AGS was examined by MTT assay. The
exponentially growing cells were treated with various concentrations
of 5-day old Hpn ﬁbrils for 8 h and cell viability was measured. As
shown in Fig. 2a, Hpn ﬁbrils caused marked growth inhibition and
signiﬁcantly decreased cell viabilities in a dose-dependent manner.
The IC50 value for 8 h treatment was determined to be around 4.2 μM.
This concentration has been used thereafter as a standard dose to treat
the cells.
We investigated further the effects of Hpn ﬁbrils on cell cycle
regulation (Fig. 2b). The treatment with 4.2 μM Hpn proteins caused
AGS cell arrest at G2/M phase (a marked increase to 40.0% of total
populations from 19.5% in the untreated group), with concomitant
decreased populations in the G0/G1 phase (57.1% to 33.2%). Cell
population in sub-G0/G1 phase increasedmildly from 0.6% to 4.2% upon
Hpn treatment, indicating the presence of cell death either through
apoptotic or non-apoptotic pathways. The detailed death pathways aresays of the ﬂuorescent dyes ThT and Congo red. (a) Kinetics of formation of amyloid-like
ngo red and Congo red bound to Hpn ﬁbrils. (c–e) Time course of ﬁbril formation of Hpn
e of the ﬁbril growth curve. (d) Mature ﬁbrils were dominant at early plateau phase.
Fig. 2. Cytotoxicity of Hpn amyloid-like ﬁbrils on AGS cells. (a) AGS cells were plated in 96-well plates at 5000 cells/well and incubated overnight in 100 μl of culture medium. The
cells were then treated with different doses of 5-day old Hpn ﬁbrils for 8 h. Cell viability was measured by MTT assay. Untreated cell populations were set as 100%. Data are mean
values from three independent experiments. (b) Hpn ﬁbrils induced cell cycle arrest in AGS cells as reﬂected by ﬂow cytometric analysis. Left, control cells; Right, cells treated with
4.2 μM5-day old Hpn ﬁbrils for 8 h. The analysis of the cell cycle throughWinMDI revealed a decrease in the cell population in G0/G1 phase and a marked increase in the G2/M and a
mild increase in the sub-G0 populations.
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of Hpn ﬁbrils under the conditions used in this present study.
Considering the major risk factor for peptic ulceration and gastric
cancer duringH. pylori infections to be the ensuing gastric inﬂammatory
response, rather than the direct gastric cell death [34], we do not intend
to increase the dose or extend the treatment time span to induce severe
cell death.3.3. Effects of Hpn ﬁbrils on membrane properties of AGS
It was proposed that the β-amyloid peptide is imported into the
mitochondria via the translocase of the outer membrane (TOM)
import machinery [35], and exerts its toxicity intracellularly [36]. JC-1
is a cationic dye that exhibits membrane potential-dependent
accumulation. The dye emits red ﬂuorescent J-aggregates in mito-
chondria with high ΔΨm, and produces green ﬂuorescence in the
cytoplasm andmitochondriawith lowΔΨm. Fluorescence studies here
revealed a decrease of the mitochondrial membrane potential in the
AGS cells upon the treatment with Hpn ﬁbrils at its IC50, as evidenced
by the lack of orange ﬂuorescence of J-aggregate at hyperpolarized
membrane potentials (Fig. 3b). The untreated AGS cells exhibited a
marked increase in orangeﬂuorescence comparedwith the cells under
Hpn treatment (Fig. 3a). A decrease of the membrane potential, i.e., a
decrease of the negative ions inmatrix, would cause a lower barrier for
the Hpn protein to cross, as Hpn is negatively charged at pH 7.2 (pI
~6.2). This would in turn increase the import of Hpn proteins into the
mitochondria to exert their toxicity.Fig. 3. Hpn ﬁbrils disrupted the integrity of the mitochondrial membrane. (a) Hpn induced m
(b) Cells were treated with 4.2 μM 5-day old Hpn for 8 h. In ﬂuorescent microscopy imag
ﬂuorescence of J-aggregate at hyperpolarized membrane potentials. (c) Intracellular ATP lev
determined using a luciferase–luciferin enzymatic assay. The ATP level in untreated cells wA decrease in mitochondrial membrane potential may be associ-
ated with defects in aerobic respiration and ATP synthesis. The ATP
levels in AGS cells after Hpn treatment were determined by ATP
bioluminescence assay. The data showed that the ATP content of the
cells was depleted with time upon treatment with 4.2 μM Hpn ﬁbrils
(Fig. 3c). Thus we have demonstrated that amyloidogenetic Hpn
cytotoxicity leads to the collapse of cell membrane potential and
reduction in intracellular ATP levels, all of which indicate the presence
of signiﬁcant mitochondrial dysfunction. The contribution of ATP to
cell cycle progresswasmonitored previously on humanpromyelocytic
leukemic cells, which suggested that the successful passage through
G2 intomitosis and G1 into S phase is relied upon themaintenance of a
minimal ATP content to satisfy the energy requirement [37]. Therefore
the disruption of the mitochondrial function may be closely related to
the AGS cell cycle arrest in the G2/M phase upon the treatment by Hpn
ﬁbrils.
4. Discussions
Amyloid ﬁbril formation is traditionally proposed to be the
characteristic of uncontrolled protein misfolding and aggregation
that is closely associated with various systemic and neurodegenera-
tive disorders [1,38]. However growing evidences have suggested that
amyloidogenesis may be a common property of some proteins with
normal cellular functions [39,40]. This present work demonstrates
that Hpn polymerizes with nucleation-dependent kinetics, and the
formation of amyloid-like ﬁbrils is demonstrated with transmission
electron microscopy and amyloid-speciﬁc dye binding assay. It woulditochondrial membrane potential depletion. The control cells without Hpn treatment.
es, mitochondrial membrane depolarization was identiﬁed due to the lack of orange
els of AGS cells. Cells were taken at timed intervals and the intracellular ATP levels were
as set at 100%. Data are mean values from three independent experiments.
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formation of amyloid ﬁbril of Hpn and the in vivo biological functions.
Histidine-rich proteins, such as Hpn, HRC, imidazole glycerol-
phosphate dehydratase, tend to form oligomers, and the propensity
seems to be positively correlated with the percentage of histidines
[13]. The oligomerization of Hpn is inhibited by the presence of high
concentrations of imidazole. Therefore we suggested that the
oligomerization is possibly induced by aromatic stacking between
intra- or inter-molecule imidazole side chains of histidine residues
[13]. This hypothesis is supported by the remarkable occurrence of
aromatic residues in many amyloid-like proteins [41], and the well-
known role of aromatic stacking in the processes of self-assembly in
chemistry [42,43]. The restricted geometry of planar aromatic
stacking between histidine side chains may provide an energetic
contribution as well as dimensional orientation for the formation of
amyloid-like ﬁbril structure.
Secreted and translocated proteins are of great interest from the
perspective of pathogen–host interactions. H. pylori uses a variety of
secreted and translocated virulence factors, such as the outer
membrane adhesions, secreted extracellular enzymes and translo-
cated effector proteins, to adapt to its mucus colonization and exert its
pathogenicity. The two major virulence factors are the active
vacuolating toxin VacA [44] and the 40-kbp cag pathogenicity island
encoding a cytotoxin-associated antigen A (CagA) as well as its type-
IV secretion system [45]. The histidine-rich protein Hpn is found to be
present in the bacterial cytosol, the membrane [21] and the
extracellular space. Further study indicated that part of this protein
may be secreted through a porin protein HopD (Q. Z. and R. G.,
unpublishedwork). It is not yet clear whether Hpn forms amyloid-like
structure in the cytoplasm of H. pylori or in the extracellular space.
However, this protein cannot be identiﬁed in our previous proteomic
work to characterize the proteome of either total cellular proteins or
metal-bound fractions [46,47]. Considering the mild characteris-
tics (molecular weight ~16 kDa in SDS-PAGE, pI ~6.2, hydrophilic
property and high abundance ~2% of proteins expressed in H. pylori)
of themonomer, Hpnmay have formed amyloid-like oligomers in vivo
or interacted with the membrane either as monomers or oligomers.
The possible mechanisms underlying the cytotoxicity of amyloid
peptides are divided into direct (membrane instability through pore
formation in cellular membranes and permeation effect of amyloido-
genic bundles [48]) or indirect effects (formation of reactive oxygen
and nitrogen species, abnormalities in cell redox systems, loss of
function for proteins upon aggregation and hyper-phosphorylation of
proteins accumulated in aggregative protein deposits [49]) [50]. The
pore formation or permeation effects of Hpn in membranes has been
veriﬁed by an in vitro studywith lipid large unilamellar vesicles (LUV)
which showed that Hpn oligomers can release the ﬂuorescent dye
calcein without the collapse of the LUV structure (Q. Z. and R. G., un-
published work). It has been reported that at late-exponential phase,
the supernatant of H. pylori cultivation contains some proteins,
including urease and HspB, which are localized exclusively in the
intracellular space in most other bacteria and are supposed to be
released through speciﬁc secretion rather than autolysis [51].
However, the transporter(s) responsible for the speciﬁc secretion of
these proteins are not yet clariﬁed. Based on the work conducted in
our lab and the colleagues', we proposed the following in vivo
biological functions for Hpn: (1) the cytoplasmic presence of Hpn in
H. pylori functions as a nickel storage protein to deliver nickel ions to
the urease chaperones upon pH falling down; (2) Hpn proteins
anchored on the membrane and in the periplasm work as a metal
reservoir and a buffer system through the imidazole group of histidine
residues; (3) Hpn proteins on the bacterial membrane may form
porins to allow for the release of some cellular proteins; (4) the
extracellular Hpn contributes in some way to the pathology of H.
pylori with regard to such gastric diseases as gastritis, peptic
ulceration, gastric carcinoma and MALT lymphoma; and (5) Hpnproteins may be transported through the blood–brain barrier and play
roles in the progression of Alzheimer's disease as evidenced by the
identiﬁed direct association between chronic H. pylori infections and
the AD progression [52–54]. Apparently many efforts are required to
determine and verify the proposed roles of Hpn in vivo.
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